| License: Creative Commons Attribution Non-commercial No Derivatives 4.0 PDF - Published Version (6MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-745799
- DOI to cite this document:
- 10.5283/epub.74579
Abstract
The treatment of stress-related disorders such as anxiety and depression is still challenging. One potential therapeutical option are neurosteroids. Their synthesis is promoted by ligands of the mitochondrial translocator protein 18 kDa (TSPO). We tested the TSPO ligand etifoxine (ETX) in a rat model of hyper-anxiety and depression-like behavior, i.e., in female and male HAB (high anxiety-related ...

Owner only: item control page

Download Statistics